No connection

Search Results

FC

BEARISH
$21.61 Live
Franklin Covey Co. · NYSE
Target $28.33 (+31.1%)
$11.16 52W Range $24.7

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
$243.6M
P/E
N/A
ROE
-4.2%
Profit margin
-0.9%
Debt/Equity
0.02
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Franklin Covey exhibits severe financial fragility, highlighted by a critical Piotroski F-Score of 2/9, indicating weak operational health. While the company maintains a very low debt-to-equity ratio (0.02), it suffers from a significant liquidity crisis with a current ratio of 0.63 and a quick ratio of 0.42. Stagnant revenue growth (0.10% YoY) and a disastrous recent earnings track record—missing 4 of the last 4 estimates with an average surprise of -82.73%—suggest a failing business model or a difficult transition. Despite a low Price-to-Sales ratio, the combination of negative profit margins and a bearish technical trend (10/100) outweighs the analyst target price.

Key Strengths

Very low leverage (Debt/Equity: 0.02)
Strong Gross Margin (75.85%)
Low Price-to-Sales ratio (0.93)
Reasonable PEG ratio (0.95) based on forward estimates
Positive ROA (3.17%) despite negative ROE

Key Risks

Critical liquidity risk (Current Ratio 0.63, Quick Ratio 0.42)
Severe operational deterioration (Piotroski F-Score 2/9)
Stagnant top-line growth (0.10% YoY)
Consistent and significant earnings misses (0/4 beats in last 4 quarters)
Negative net profit margins (-0.88%)
AI Fair Value Estimate
Based on comprehensive analysis
$18.5
-14.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
45
Future
25
Past
30
Health
20
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score 2/9, Liquidity crunch, Earnings trajectory, Stagnant revenue
Confidence
90%
Value
45/100

Trades at a low multiple of sales, but lacks the earnings to justify a traditional P/E valuation.

Positives
  • P/S under 1.0
  • PEG < 1.0
Watchpoints
  • High Price/Book (6.36)
  • Negative profit margins
Future
25/100

Growth metrics are non-existent and earnings reliability is very low.

Positives
  • Forward P/E suggests expected return to profitability
Watchpoints
  • Revenue growth is nearly flat (0.10%)
  • Extreme negative earnings surprises (-82.73% avg)
Past
30/100

Long-term value destruction despite short-term volatility.

Positives
  • Recent 1-month price spike (+43%)
Watchpoints
  • 5-year return is -30%
  • 3-year return is -40.4%
Health
20/100

Severe weakness in short-term liquidity and overall financial health scores.

Positives
  • Negligible long-term debt
Watchpoints
  • Piotroski F-Score 2/9
  • Current Ratio < 1.0
  • Quick Ratio < 1.0
Dividend
0/100

Non-dividend paying stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$21.61
Analyst Target
$28.33
Upside/Downside
+31.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for FC and closest competitors.

Updated 2026-04-24
FC
Franklin Covey Co.
Primary
5Y
-30.0%
3Y
-40.4%
1Y
+4.2%
6M
+15.7%
1M
+43.0%
1W
-8.3%
PTN
Pitanium Limited
Peer
5Y
+173.4%
3Y
+173.4%
1Y
+173.4%
6M
0.0%
1M
0.0%
1W
0.0%
LMN
Limoneira Company
Peer
5Y
-18.6%
3Y
-23.6%
1Y
-19.5%
6M
-10.8%
1M
-5.7%
1W
-0.7%
AFR
Forafric Global PLC
Peer
5Y
-4.0%
3Y
-13.3%
1Y
+13.6%
6M
+14.5%
1M
-3.0%
1W
-1.3%
BYN
Beyond Meat, Inc.
Peer
5Y
-99.6%
3Y
-96.2%
1Y
-80.0%
6M
-73.4%
1M
-24.0%
1W
-17.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
16.13
PEG Ratio
0.95
P/B Ratio
6.36
P/S Ratio
0.93
EV/Revenue
0.88
EV/EBITDA
12.31
Market Cap
$243.6M

Profitability

Profit margins and return metrics

Profit Margin -0.88%
Operating Margin -0.06%
Gross Margin 75.84%
ROE -4.17%
ROA 3.17%

Growth

Revenue and earnings growth rates

Revenue Growth +0.1%
Earnings Growth N/A
Q/Q Revenue Growth +0.06%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.02
Low debt
Current Ratio
0.63
Weak
Quick Ratio
0.42
Poor
Cash/Share
$1.22

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q1 2026

Revenue
$0.1B
Gross Margin
75.9%
Op. Margin
-0.1%
Net Margin
-3.3%
Total Assets
$0.2B
Liabilities
$0.2B
Equity
$0.0B
Debt/Equity
4.43x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
81%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-01
$N/A
2026-04-01
$-0.04
-152.3% surprise
2026-01-07
$0.04
-72.3% surprise
2025-11-05
$0.34
-23.6% surprise

Consumer Defensive Sector Comparison

Comparing FC against 163 companies in the Consumer Defensive sector (9 bullish, 58 neutral, 96 bearish)
Return on Equity (ROE)
-4.17%
This Stock
vs
-12.82%
Sector Avg
-67.4% (Below Avg)
Profit Margin
-0.88%
This Stock
vs
-8.09%
Sector Avg
-89.1% (Weaker)
Debt to Equity
0.02
This Stock
vs
1.92
Sector Avg
-98.9% (Less Debt)
Revenue Growth
0.1%
This Stock
vs
115.92%
Sector Avg
-99.9% (Slower)
Current Ratio
0.63
This Stock
vs
2.33
Sector Avg
-73.1% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

WHITMAN ROBERT A
Director
Gift
2026-04-07
26,258 shares
WHITMAN ROBERT A
Director
Gift
2026-01-29
4,834 shares
MCNAMARA DONALD J
Director
Stock Award
2026-01-23
5,778 shares
CHOW ANNE H
Director
Stock Award
2026-01-23
5,778 shares
CUFFIE CRAIG
Director
Stock Award
2026-01-23
5,778 shares
VAN BEVER DEREK CM
Director
Stock Award
2026-01-23
5,778 shares
RIVERA EFRAIN
Director
Stock Award
2026-01-23
5,778 shares
PHILLIPS NANCY R
Director
Stock Award
2026-01-23
5,778 shares
WHITMAN ROBERT A
Director
Stock Award
2026-01-23
5,778 shares
DOM COLLEEN D
Chief Operating Officer
Stock Award
2025-11-21
3,014 shares
WALKER PAUL S
Chief Executive Officer
Stock Award
2025-11-21
19,585 shares
HATCH ANTHONY DEREK
Officer
Stock Award
2025-11-21
1,357 shares
COVEY MICHAEL SEAN MERRILL
Officer
Stock Award
2025-11-21
3,315 shares
WHITMAN ROBERT A
Director
Stock Award
2025-11-21
19,143 shares
DOM COLLEEN D
Chief Operating Officer
Stock Award
2025-11-13
5,108 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-Q
10-Q
2026-04-08

FC filed its quarterly Form 10-Q on April 8, 2026. Specific financial highlights and risk factors were not provided in the available metadata.

8-K
8-K
2026-04-01

FC reported its first-quarter financial results for the period ending March 31, 2026.

8-K
8-K
2026-03-18

FC filed an 8-K on March 18, 2026, likely to announce its annual financial results.

8-K
8-K
2026-01-23

FC filed an 8-K on January 23, 2026, likely to announce its fourth quarter and full-year financial results.

10-Q
10-Q
2026-01-09

FC filed its quarterly Form 10-Q on January 9, 2026. Due to the absence of provided excerpts, specific financial highlights and risk factors are unavailable for summary.

8-K
8-K
2026-01-07

FC filed an 8-K on January 7, 2026, likely to report its year-end financial results for the preceding fiscal year.

8-K
8-K
2025-12-22
DEF 14A
DEF 14A
2025-12-18

FC filed a Definitive Proxy Statement on December 18, 2025, providing shareholders with necessary information and voting materials for an upcoming meeting.

8-K/A
8-K/A
2025-11-24

FC filed an amendment to a previously submitted Current Report on Form 8-K.

10-K
10-K
2025-11-12

FC submitted its annual 10-K filing on November 12, 2025. The provided excerpts consist of the table of contents and general forward-looking statement disclosures, but do not contain specific financial highlights or detailed risk factors.

8-K
8-K
2025-11-05
8-K
8-K
2025-10-22
8-K
8-K
2025-08-07
10-Q
10-Q
2025-07-08
8-K
8-K
2025-07-02
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
3 analysts
Barrington Research
2026-04-02
Maintains
Outperform Outperform
Barrington Research
2026-03-25
Maintains
Outperform Outperform
Barrington Research
2026-01-20
Maintains
Outperform Outperform
Barrington Research
2026-01-08
Maintains
Outperform Outperform
Barrington Research
2025-12-11
Maintains
Outperform Outperform
Barrington Research
2025-11-06
Maintains
Outperform Outperform

Past News Coverage

Recent headlines mentioning FC from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile